checkAd

     101  0 Kommentare Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering - Seite 3

    Aktuelle Themen


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors

    Seite 3 von 3
    Calidi Biotherapeutics, Inc. Announces Closing of $6.1 Million Public Offering - Seite 3 Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 …

    Schreibe Deinen Kommentar

    Disclaimer